Modified citrus pectin is a plant-based dietary supplement with very preliminary evidence of anticancer and antimetastatic effects.

How can modified citrus pectin help you? What the research says

We summarize the clinical evidence for each medical benefit here. We begin with our assessment of the strength of evidence within each category, followed by a brief summary of individual studies or reviews of several studies. In assessing the strength of evidence, we consider the study design, number of participants, and the size of the treatment effect (how much outcomes changed with treatment).

To see more details, click the plus sign to the right of any section.

Improving treatment outcomes

Is modified citrus pectin linked to improved survival? Is it linked to less cancer growth or metastasis? Does it enhance the anticancer action of other treatments or therapies? We present the evidence.

Preclinical evidence is listed in Are you a health professional? ›

Cancer as a whole

Weak evidenceone or more case studies, supported by animal evidence OR small treatment effects of limited clinical significance OR studies with no controls OR weak trends of effects (this is the CancerChoices definition; other researchers and studies may define this differently) of clinical response and stable disease among a few people with various solid tumors treated with MCP

Prostate cancer

Weak evidence of better disease markers (PSA) after localized treatment for biochemically relapsed prostate cancer among people with biochemical PSA failure treated with MCP

Optimizing your body terrain

Does modified citrus pectin promote an environment within your body that is less supportive of cancer development, growth, or spread? We present the evidence.

The only published evidence we have found regarding MCP’s use in improving body terrainthe internal conditions of your body, including nutritional status, fitness, blood sugar balance, hormone balance, inflammation and more factors is preclinical—involving cells, tissues, or lab animals. Studies are listed in Are you a health professional? ›

Managing side effects and promoting wellness

Is modified citrus pectin linked to fewer or less severe side effects or symptoms? Is it linked to less toxicity from cancer treatment? Does it support your quality of life or promote general well-being? We present the evidence.

Breathing difficulties

Weak evidenceone or more case studies, supported by animal evidence OR small treatment effects of limited clinical significance OR studies with no controls OR weak trends of effects (this is the CancerChoices definition; other researchers and studies may define this differently) of fewer breathing difficulties among people with various solid tumors treated with MCP

Changes in appetite

Weak evidence of less appetite loss among people with various solid tumors treated with MCP

Fatigue

Weak evidence of less fatigue among people with various solid tumors treated with MCP

Pain

Weak evidence of less pain among people with various solid tumors treated with MCP

Quality of life and physical function

Weak evidence of better physical functioning, role functioning, social functioning, and global health status among people with various solid tumors treated with MCP

Sleep disruption

Weak evidence of less insomnia among people with various solid tumors treated with MCP

Keep reading about modified citrus pectin

Author

Nancy Hepp, MS

Lead Researcher
View profile

Ms. Hepp is a researcher and communicator who has been writing and editing educational content on varied health topics for more than 20 years. She serves as lead researcher and writer for CancerChoices and also served as the first program manager. Her graduate work in research and cognitive psychology, her master’s degree in instructional design, and her certificate in web design have all guided her in writing and presenting information for a wide variety of audiences and uses. Nancy’s service as faculty development coordinator in the Department of Family Medicine at Wright State University also provided experience in medical research, plus insights into medical education and medical care from the professional’s perspective.

Nancy Hepp, MS Lead Researcher

Reviewer

Andrew Jackson, ND

Research Associate
View profile

Andrew Jackson, ND, serves as a CancerChoices research associate. As a naturopathic physician practicing in Kirkland, Washington, he teaches critical evaluation of the medical literture at Bastyr University in Kenmore, Washington. His great appreciation of scientific inquiry and the scientific process has led him to view research with a critical eye.

Andrew Jackson, ND Research Associate

Last update: December 18, 2023

Last full literature review: April 2023

CancerChoices provides information about integrativein cancer care, a patient-centered approach combining the best of conventional care, self care, and evidence-informed complementary care in an integrated plan cancer care. We review complementaryin cancer care, complementary care involves the use of therapies intended to enhance or add to standard conventional treatments; examples include supplements, mind-body approaches such as yoga or psychosocialtherapy, and acupuncture therapies and self carelifestyle actions and behaviors that may impact cancer outcomes; examples include eating health-promoting foods, limiting alcohol, increasing physical activity, and managing stress practices to help patients and professionals explore and integrate the best combination of conventionalthe cancer care offered by conventionally trained physicians and most hospitals; examples are chemotherapy, surgery, and radiotherapy and complementary therapies and practices for each person.

Our staff have no financial conflicts of interest to declare. We receive no funds from any manufacturers or retailers gaining financial profit by promoting or discouraging therapies mentioned on this site.

Learn more

References[+]